TMS Therapy for Bipolar Depression in Colorado Springs

Treating depressive episodes without increasing pharmacological complexity.

Bipolar disorder presents a fundamental treatment challenge: antidepressants used for depressive phases can precipitate manic or hypomanic switching, and mood stabilizers carry significant side effect burdens. Patients with bipolar I and II often cycle through multiple medication combinations with incomplete control of depressive symptoms — which account for the majority of symptomatic time in bipolar II.

Growing clinical evidence supports TMS as an effective option for the depressive phase of bipolar disorder. Because TMS acts through focused magnetic stimulation rather than serotonergic or dopaminergic pharmacology, it does not trigger the cascade mechanism associated with antidepressant-induced mania. Published clinical literature does not support an elevated mania-switching risk with TMS.

• 01
  No antidepressant-type mania inductionTMS does not act through serotonergic or dopaminergic pathways. Published data does not show elevated mania-switching rates with TMS vs. other interventions.
• 02
  Reduces overall medication burdenFor patients already managing complex pharmacological regimens, TMS offers the possibility of treating depressive episodes without adding another systemic medication.
• 03
  Compatible with mood stabilizersTMS has no pharmacological activity and does not interact with lithium, valproate, lamotrigine, or other mood stabilizers.